
Iterum Therapeutics Plc (ITRM) is expecting -12.70% growth in the next quarter: What can investors do to maximize their returns?
On Friday, Iterum Therapeutics Plc (NASDAQ: ITRM) was -6.47% drop from the session before settling in for the closing price of $0.98. A 52-week range